Dynavax to Present at the William Blair 40th Annual Growth Stock Conference
EMERYVILLE, Calif., May 28, 2020 (GLOBE NEWSWIRE) — Dynavax Technologies Corporation (Nasdaq: DVAX), a biopharmaceutical company focused on developing and […]
Zentalis Pharmaceuticals to Participate in Jefferies Virtual Healthcare Conference
NEW YORK and SAN DIEGO, May 28, 2020 (GLOBE NEWSWIRE) — Zentalis Pharmaceuticals (Nasdaq: ZNTL), a clinical-stage biopharmaceutical company focused on […]
ZAGG Inc Reports First Quarter 2020 Results
SALT LAKE CITY, May 28, 2020 (GLOBE NEWSWIRE) — ZAGG Inc (Nasdaq: ZAGG) (the “Company”), a leading global mobile lifestyle […]
CytomX Therapeutics to Participate at Upcoming Healthcare Conferences
SOUTH SAN FRANCISCO, Calif., May 28, 2020 (GLOBE NEWSWIRE) — CytomX Therapeutics, Inc. (Nasdaq: CTMX), a clinical-stage oncology-focused biopharmaceutical company […]
Zumiez Announces Participation in the William Blair 40th Annual Growth Stock Conference
LYNNWOOD, Wash., May 28, 2020 (GLOBE NEWSWIRE) — Zumiez Inc. (NASDAQ: ZUMZ) a leading specialty retailer of apparel, footwear, equipment […]
Lyra Therapeutics Reports First Quarter 2020 Financial Results and Provides Corporate Update
WATERTOWN, Mass., May 28, 2020 (GLOBE NEWSWIRE) — Lyra Therapeutics, Inc. (Nasdaq: LYRA), a clinical-stage therapeutics company focused on the […]
Kornit Digital to Present at Upcoming Virtual Investor Conferences
ROSH HA’AYN, Israel, May 28, 2020 (GLOBE NEWSWIRE) — Kornit Digital (Nasdaq: KRNT), a worldwide market leader in digital textile […]
UNITY Biotechnology to Participate in the Goldman Sachs 41st Annual Global Healthcare Conference
SAN FRANCISCO, May 28, 2020 (GLOBE NEWSWIRE) — UNITY Biotechnology (“UNITY”) [NASDAQ:UBX], a biotechnology company developing therapeutics to extend healthspan […]
Karyopharm Reports Positive Phase 3 BOSTON Data in Oral Presentation at the American Society of Clinical Oncology 2020 Virtual Scientific Program
— Combination of Once-Weekly XPOVIO® (selinexor), Once-Weekly Velcade® (bortezomib) and Dexamethasone (SVd) Prolonged Median Progression-Free Survival by 47% Compared to […]
Zscaler Reports Third Quarter Fiscal 2020 Financial Results
Revenue grows 40% year-over-year to $110.5 millionCalculated billings grow 55% year-over-year to $131.3 millionDeferred revenue grows 42% year-over-year to $300.8 […]
